Trevi Therapeutics Reaches 75% of Enrollment Target for Phase 2B IPF Chronic Cough Study

Trevi Therapeutics已達到20億IPF慢性咳嗽研究的75%的招募目標

MT Newswires · 2024/12/12 21:23

Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.

登入免費觀看全文

登入/註冊

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。更多信息

Trevi Therapeutics Reaches 75% of Enrollment Target for Phase 2B IPF Chronic Cough Study

Trevi Therapeutics Reaches 75% of Enrollment Target for Phase 2B IPF Chronic Cough Study

風險及免責聲明

聲明